Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaromir Mikl

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Inherited Metabolic Disease|September 10, 2017
Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)Barbara K Burton, Virginie Jego, Jaromir Mikl, et al.
Health and Quality of Life Outcomes|November 10, 2018
Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)Maria Mattera, Margaret K Vernon, Mireia Raluy-Callado, et al.
Journal of Patient-Reported Outcomes|July 25, 2019
Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact QuestionnaireMagdalena Harrington, Asha Hareendran, Anne Skalicky, et al.
The Primary Care Companion for CNS Disorders|March 22, 2023
The Burden of Attention-Deficit/Hyperactivity Disorder in Adults: A Real-World Linked Data StudyLulu Lee, Srikesh Arunajadai, Jaromir Mikl, et al.
AAPS Pharmscitech|October 9, 2014
A risk-based approach to management of leachables utilizing statistical analysis of extractablesCheryl L M Stults, Jaromir Mikl, Oliver Whelehan, et al.
Journal of Attention Disorders|July 5, 2022
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHDMarc Cataldo, Graeme Donnelly, Andrew J Cutler, et al.
Journal of Attention Disorders|January 20, 2024
Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of EffectNate Way, Jaromir Mikl, Marc Cataldo, et al.
Journal of Studies on Alcohol and Drugs|May 27, 2025
Pharmacologic Treatment of Insomnia Reduces Risk of Return to Alcohol Use in Patients in Recovery From Alcohol Use DisorderJaromir Mikl, Tiange Yu, Sachin Singh, et al.
The Pediatric Infectious Disease Journal|September 3, 2013
Efficacy and safety of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents: 5 years of experienceJuan C Salazar, Pedro Cahn, Marinella Della Negra, et al.
Chemical Research in Toxicology|September 9, 2017
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury BiomarkersLiuxi Chen, James Smith, Jaromir Mikl, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Inherited Metabolic Disease|September 10, 2017
Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)Barbara K Burton, Virginie Jego, Jaromir Mikl, et al.
Health and Quality of Life Outcomes|November 10, 2018
Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)Maria Mattera, Margaret K Vernon, Mireia Raluy-Callado, et al.
Journal of Patient-Reported Outcomes|July 25, 2019
Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact QuestionnaireMagdalena Harrington, Asha Hareendran, Anne Skalicky, et al.
The Primary Care Companion for CNS Disorders|March 22, 2023
The Burden of Attention-Deficit/Hyperactivity Disorder in Adults: A Real-World Linked Data StudyLulu Lee, Srikesh Arunajadai, Jaromir Mikl, et al.
AAPS Pharmscitech|October 9, 2014
A risk-based approach to management of leachables utilizing statistical analysis of extractablesCheryl L M Stults, Jaromir Mikl, Oliver Whelehan, et al.
Journal of Attention Disorders|July 5, 2022
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHDMarc Cataldo, Graeme Donnelly, Andrew J Cutler, et al.
Journal of Attention Disorders|January 20, 2024
Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of EffectNate Way, Jaromir Mikl, Marc Cataldo, et al.
Journal of Studies on Alcohol and Drugs|May 27, 2025
Pharmacologic Treatment of Insomnia Reduces Risk of Return to Alcohol Use in Patients in Recovery From Alcohol Use DisorderJaromir Mikl, Tiange Yu, Sachin Singh, et al.
The Pediatric Infectious Disease Journal|September 3, 2013
Efficacy and safety of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents: 5 years of experienceJuan C Salazar, Pedro Cahn, Marinella Della Negra, et al.
Chemical Research in Toxicology|September 9, 2017
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury BiomarkersLiuxi Chen, James Smith, Jaromir Mikl, et al.
Pageof 2